The efficacy and safety of crizotinib in patients with ROS1 positive advanced stage NSCLC: The real-world experience from Turkey

Kilickap, S.Olmez, O. F.Cicin, I.Demirci, U.Alan, O.Cabuk, D.Sakalar, T.2024-02-232024-02-2320180923-75341569-8041https://hdl.handle.net/20.500.12452/1730043rd ESMO Congress (ESMO) -- OCT 19-23, 2018 -- Munich, GERMANY[Abstract Not Availabe]eninfo:eu-repo/semantics/closedAccess[Keyword Not Available]The efficacy and safety of crizotinib in patients with ROS1 positive advanced stage NSCLC: The real-world experience from TurkeyConference Object29505505Q1WOS:000459277303171Q1